Niitsu Y, Watanabe N, Umeno H, Sone H, Neda H, Yamauchi N, Maeda M, Urushizaki I
Department of Internal Medicine, Sapporo Medical College, Japan.
Cancer Res. 1988 Feb 1;48(3):654-7.
Synergy in cytotoxic effect between recombinant human tumor necrosis factor and hyperthermia (incubation at 38.5 degrees C or 40 degrees C) was observed to occur against L-M (mouse tumorigenic fibroblast) cells and shown to be related to an accelerated turnover rate of recombinant human tumor necrosis factor-receptor complex under elevated temperatures rather than to changes in number of cell receptors or binding strength. However, no synergy in cytotoxic effect was observed to occur against human embryonic lung (HEL) cells. A clearly synergistic inhibition of metastatic tumor growth by combined administration of recombinant human tumor necrosis factor (300 units) and whole-body hyperthermia (40 degrees C, 30 min) was also observed in BALB/c mice previously given injections of 1 x 10(6) Meth-A (MH) cells/mouse via tail vein, neither of which alone resulted in significant inhibition.
观察到重组人肿瘤坏死因子与热疗(在38.5摄氏度或40摄氏度孵育)对L-M(小鼠致瘤性成纤维细胞)细胞的细胞毒性作用具有协同效应,且该协同效应与重组人肿瘤坏死因子-受体复合物在升高温度下的周转速率加快有关,而非与细胞受体数量或结合强度的变化有关。然而,未观察到对人胚肺(HEL)细胞的细胞毒性作用有协同效应。在先前经尾静脉注射1×10⁶ Meth-A(MH)细胞/小鼠的BALB/c小鼠中,还观察到重组人肿瘤坏死因子(300单位)与全身热疗(40摄氏度,30分钟)联合给药对转移性肿瘤生长有明显的协同抑制作用,单独使用这两种方法均未产生显著抑制作用。